Recurrent Clostridioides difficile Infection in Patients Treated With Bezlotoxumab: Systematic Review and Meta-Analysis

被引：0
|
作者：
Mohamed, Mouhand F. [1 ]
Ward, Christopher [2 ]
Beran, Azizullah [3 ]
Abdallah, Mohamed [4 ]
Kelly, Colleen [1 ]
机构：
[1] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Brown Univ, Warren Alpert Med Sch, East Providence, RI USA
[3] Univ Toledo, 2801 W Bancroft St, Toledo, OH 43606 USA
[4] Univ Minnesota, Med Ctr, Minneapolis, MN 55455 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S155
引用
收藏
页码：S110 / S111
页数：2
相关论文
共 50 条
  • [21] Outcomes of Patients Receiving Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection - A Multicenter Study
    Chaar, Abdelkader
    Damianos, John
    Rizwan, Rabia
    Nawaz, Ahmad
    Feuerstadt, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S99 - S100
  • [22] Efficacy of Saccharomyces boulardii for Prevention of Clostridioides difficile Infection: A Systematic Review and Meta-Analysis
    Tariq, Raseen
    Yadav, Devvrat
    Tahir, Muhammad Waqas
    Sehgal, Kanika
    Pardi, Darrell
    Khanna, Sahil
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S59 - S60
  • [23] Body mass index and risk of clostridioides difficile infection: a systematic review and meta-analysis
    Charoenngam, Nipith
    Ponvilawan, Ben
    Thongpiya, Jerapas
    Yingchoncharoen, Pitchaporn
    Chaikijurajai, Thanat
    Chaisidhivej, Natapat
    Apovian, Caroline M.
    Ungprasert, Patompong
    INFECTION, 2022, 50 (03) : 725 - 737
  • [24] Body mass index and risk of clostridioides difficile infection: a systematic review and meta-analysis
    Nipith Charoenngam
    Ben Ponvilawan
    Jerapas Thongpiya
    Pitchaporn Yingchoncharoen
    Thanat Chaikijurajai
    Natapat Chaisidhivej
    Caroline M. Apovian
    Patompong Ungprasert
    Infection, 2022, 50 : 725 - 737
  • [25] Oral Fecal Microbiota Transplantation Capsules Are Effective and Safe for Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis
    Du, Charles
    Luo, Yuying
    Walsh, Samantha
    Grinspan, Ari M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S98 - S99
  • [26] Oral Fecal Microbiota Transplant Capsules Are Safe and Effective for Recurrent Clostridioides difficile Infection A Systematic Review and Meta-Analysis
    Du, Charles
    Luo, Yuying
    Walsh, Samantha
    Grinspan, Ari
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (04) : 300 - 308
  • [27] Resolution rates in clinical trials for microbiota restoration for recurrent Clostridioides difficile infection: an updated systematic review and meta-analysis
    Tariq, Raseen
    Pardi, Darrell S. S.
    Khanna, Sahil
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [28] Efficacy of bezlotoxumab to prevent recurrent Clostridioides difficile infection (CDI) in patients with multiple prior recurrent CDI
    Skinner, Andrew M.
    Tan, Xing
    Westman, Colin
    Birris, Thomas
    Drwiega, Emily N.
    Wang, Michael S.
    Johnson, Stuart
    ANAEROBE, 2023, 84
  • [29] Bezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies
    Daniele Roberto Giacobbe
    Silvia Dettori
    Stefano Di Bella
    Antonio Vena
    Guido Granata
    Roberto Luzzati
    Nicola Petrosillo
    Matteo Bassetti
    Infectious Diseases and Therapy, 2020, 9 : 481 - 494
  • [30] Factors affecting fecal microbiota transplantation outcomes in patients with Clostridioides difficile infection: A systematic review and meta-analysis
    Zalums, A.
    Al-Abedi, A.
    Paramsothy, S.
    Leong, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 156 - 157
12345